Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.
Our initial experience with the DurAVR ® THV System has been very positive, and we look forward to providing definitive comparative evidence which could transform patient care.” “With the first ...
Operators are excited about a device that avoids transapical access, a limitation of other systems, says Gilbert Tang.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback